Is VAL or TRP more profitable?

Tower Resources has a net margin of 0.00% compared to ValiRx's net margin of -6,548.06%. Tower Resources' return on equity of -1.00% beat ValiRx's return on equity. Company Net Margins Return on Equity Return on Assets ValiRx -6,548.06% -71.49% -35.98% Tower Resources N/A -1.00% -0.05%

Does the media refer more to VAL or TRP?

In the previous week, Tower Resources had 1 more articles in the media than ValiRx. MarketBeat recorded 2 mentions for Tower Resources and 1 mentions for ValiRx. ValiRx's average media sentiment score of 0.75 beat Tower Resources' score of 0.57 indicating that ValiRx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ValiRx 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Tower Resources 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is VAL or SENX more profitable?

Serinus Energy has a net margin of -63.07% compared to ValiRx's net margin of -6,548.06%. Serinus Energy's return on equity of -51.04% beat ValiRx's return on equity. Company Net Margins Return on Equity Return on Assets ValiRx -6,548.06% -71.49% -35.98% Serinus Energy -63.07% -51.04% -7.16%

Which has higher valuation & earnings, BLVN or VAL?

Bowleven has higher earnings, but lower revenue than ValiRx. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Bowleven N/A N/A -£2.15M N/A N/A ValiRx £31.37K 51.34 -£5.71M -£0.54 N/A

Is BLVN or VAL more profitable?

Bowleven has a net margin of 0.00% compared to ValiRx's net margin of -6,548.06%. Bowleven's return on equity of -1.35% beat ValiRx's return on equity. Company Net Margins Return on Equity Return on Assets Bowleven N/A -1.35% -0.88% ValiRx -6,548.06% -71.49% -35.98%

Which has stronger earnings and valuation, VAL or IOG?

ValiRx has higher earnings, but lower revenue than IOG. ValiRx is trading at a lower price-to-earnings ratio than IOG, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio ValiRx £31.37K 51.34 -£5.71M -£0.54 N/A IOG £75.41M 0.00 -£28.45M -£0.05 N/A

Is VAL or IOG more profitable?

IOG has a net margin of -37.73% compared to ValiRx's net margin of -6,548.06%. ValiRx's return on equity of -71.49% beat IOG's return on equity. Company Net Margins Return on Equity Return on Assets ValiRx -6,548.06% -71.49% -35.98% IOG -37.73% -173.63% -0.57%

Is VAL or WTE more profitable?

Westmount Energy has a net margin of -232.19% compared to ValiRx's net margin of -6,548.06%. Westmount Energy's return on equity of -2.93% beat ValiRx's return on equity. Company Net Margins Return on Equity Return on Assets ValiRx -6,548.06% -71.49% -35.98% Westmount Energy -232.19% -2.93% -3.04%

Does the media favor VAL or WTE?

In the previous week, ValiRx and ValiRx both had 1 articles in the media. Westmount Energy's average media sentiment score of 0.84 beat ValiRx's score of 0.75 indicating that Westmount Energy is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ValiRx 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Westmount Energy 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

ValiRx (VAL) Competitors

GBX 0.12 0.00 (-2.40%)

As of 03:51 AM Eastern

Compare

VAL vs. TRP, SENX, BLVN, IOG, and WTE

Should you buy ValiRx stock or one of its competitors? ValiRx's main competitors and comparable companies include Tower Resources (TRP), Serinus Energy (SENX), Bowleven (BLVN), IOG (IOG), and Westmount Energy (WTE). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "oil & gas exploration & production" industry.

How does ValiRx compare to Tower Resources?

ValiRx (LON:VAL) and Tower Resources (LON:TRP) are both small-cap energy companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, media sentiment, analyst recommendations, dividends, earnings and profitability.

Tower Resources has lower revenue, but higher earnings than ValiRx. Tower Resources is trading at a lower price-to-earnings ratio than ValiRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ValiRx	£31.37K	51.34	-£5.71M	-£0.54	N/A
Tower Resources	N/A	N/A	-£1.02M	-£0.06	N/A

In the previous week, Tower Resources had 1 more articles in the media than ValiRx. MarketBeat recorded 2 mentions for Tower Resources and 1 mentions for ValiRx. ValiRx's average media sentiment score of 0.75 beat Tower Resources' score of 0.57 indicating that ValiRx is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ValiRx	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Tower Resources	0 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

35.4% of ValiRx shares are held by institutional investors. Comparatively, 0.0% of Tower Resources shares are held by institutional investors. 12.9% of ValiRx shares are held by company insiders. Comparatively, 16.9% of Tower Resources shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

ValiRx has a beta of 0.59, suggesting that its share price is 41% less volatile than the broader market. Comparatively, Tower Resources has a beta of 1.12, suggesting that its share price is 12% more volatile than the broader market.

Tower Resources has a net margin of 0.00% compared to ValiRx's net margin of -6,548.06%. Tower Resources' return on equity of -1.00% beat ValiRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ValiRx	-6,548.06%	-71.49%	-35.98%
Tower Resources	N/A	-1.00%	-0.05%

Summary

Tower Resources beats ValiRx on 8 of the 12 factors compared between the two stocks.

How does ValiRx compare to Serinus Energy?

ValiRx (LON:VAL) and Serinus Energy (LON:SENX) are both small-cap energy companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, institutional ownership, analyst recommendations, risk, profitability and earnings.

ValiRx has higher earnings, but lower revenue than Serinus Energy. Serinus Energy is trading at a lower price-to-earnings ratio than ValiRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ValiRx	£31.37K	51.34	-£5.71M	-£0.54	N/A
Serinus Energy	£27.51M	0.23	-£18.19M	-£7.53	N/A

In the previous week, ValiRx had 1 more articles in the media than Serinus Energy. MarketBeat recorded 1 mentions for ValiRx and 0 mentions for Serinus Energy. ValiRx's average media sentiment score of 0.75 beat Serinus Energy's score of 0.00 indicating that ValiRx is being referred to more favorably in the media.

Company	Overall Sentiment
ValiRx	Positive
Serinus Energy	Neutral

35.4% of ValiRx shares are owned by institutional investors. Comparatively, 42.4% of Serinus Energy shares are owned by institutional investors. 12.9% of ValiRx shares are owned by company insiders. Comparatively, 15.8% of Serinus Energy shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

ValiRx has a beta of 0.59, indicating that its stock price is 41% less volatile than the broader market. Comparatively, Serinus Energy has a beta of -0.63, indicating that its stock price is 163% less volatile than the broader market.

Serinus Energy has a net margin of -63.07% compared to ValiRx's net margin of -6,548.06%. Serinus Energy's return on equity of -51.04% beat ValiRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ValiRx	-6,548.06%	-71.49%	-35.98%
Serinus Energy	-63.07%	-51.04%	-7.16%

Summary

ValiRx beats Serinus Energy on 7 of the 13 factors compared between the two stocks.

How does ValiRx compare to Bowleven?

Bowleven (LON:BLVN) and ValiRx (LON:VAL) are both small-cap energy companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, earnings, media sentiment, institutional ownership and profitability.

5.4% of Bowleven shares are held by institutional investors. Comparatively, 35.4% of ValiRx shares are held by institutional investors. 79.1% of Bowleven shares are held by insiders. Comparatively, 12.9% of ValiRx shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Bowleven has a beta of 0.53, indicating that its stock price is 47% less volatile than the broader market. Comparatively, ValiRx has a beta of 0.59, indicating that its stock price is 41% less volatile than the broader market.

In the previous week, ValiRx had 1 more articles in the media than Bowleven. MarketBeat recorded 1 mentions for ValiRx and 0 mentions for Bowleven. ValiRx's average media sentiment score of 0.75 beat Bowleven's score of 0.00 indicating that ValiRx is being referred to more favorably in the news media.

Company	Overall Sentiment
Bowleven	Neutral
ValiRx	Positive

Bowleven has a net margin of 0.00% compared to ValiRx's net margin of -6,548.06%. Bowleven's return on equity of -1.35% beat ValiRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bowleven	N/A	-1.35%	-0.88%
ValiRx	-6,548.06%	-71.49%	-35.98%

Bowleven has higher earnings, but lower revenue than ValiRx.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bowleven	N/A	N/A	-£2.15M	N/A	N/A
ValiRx	£31.37K	51.34	-£5.71M	-£0.54	N/A

Summary

ValiRx beats Bowleven on 6 of the 11 factors compared between the two stocks.

How does ValiRx compare to IOG?

ValiRx (LON:VAL) and IOG (LON:IOG) are both small-cap energy companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, risk, earnings, analyst recommendations, institutional ownership, valuation and media sentiment.

IOG has a net margin of -37.73% compared to ValiRx's net margin of -6,548.06%. ValiRx's return on equity of -71.49% beat IOG's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ValiRx	-6,548.06%	-71.49%	-35.98%
IOG	-37.73%	-173.63%	-0.57%

35.4% of ValiRx shares are owned by institutional investors. Comparatively, 16.0% of IOG shares are owned by institutional investors. 12.9% of ValiRx shares are owned by company insiders. Comparatively, 29.7% of IOG shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

ValiRx has a beta of 0.59, meaning that its stock price is 41% less volatile than the broader market. Comparatively, IOG has a beta of 0.4, meaning that its stock price is 60% less volatile than the broader market.

ValiRx has higher earnings, but lower revenue than IOG. ValiRx is trading at a lower price-to-earnings ratio than IOG, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ValiRx	£31.37K	51.34	-£5.71M	-£0.54	N/A
IOG	£75.41M	0.00	-£28.45M	-£0.05	N/A

In the previous week, ValiRx had 1 more articles in the media than IOG. MarketBeat recorded 1 mentions for ValiRx and 0 mentions for IOG. ValiRx's average media sentiment score of 0.75 beat IOG's score of 0.00 indicating that ValiRx is being referred to more favorably in the media.

Company	Overall Sentiment
ValiRx	Positive
IOG	Neutral

Summary

ValiRx beats IOG on 7 of the 12 factors compared between the two stocks.

How does ValiRx compare to Westmount Energy?

ValiRx (LON:VAL) and Westmount Energy (LON:WTE) are both small-cap energy companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, media sentiment, valuation, dividends, earnings and profitability.

In the previous week, ValiRx and ValiRx both had 1 articles in the media. Westmount Energy's average media sentiment score of 0.84 beat ValiRx's score of 0.75 indicating that Westmount Energy is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ValiRx	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Westmount Energy	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

35.4% of ValiRx shares are owned by institutional investors. Comparatively, 7.9% of Westmount Energy shares are owned by institutional investors. 12.9% of ValiRx shares are owned by insiders. Comparatively, 11.1% of Westmount Energy shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

ValiRx has a beta of 0.59, meaning that its share price is 41% less volatile than the broader market. Comparatively, Westmount Energy has a beta of 1.401, meaning that its share price is 40% more volatile than the broader market.

Westmount Energy has lower revenue, but higher earnings than ValiRx. Westmount Energy is trading at a lower price-to-earnings ratio than ValiRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ValiRx	£31.37K	51.34	-£5.71M	-£0.54	N/A
Westmount Energy	N/A	N/A	-£773.04K	-£0.08	N/A

Westmount Energy has a net margin of -232.19% compared to ValiRx's net margin of -6,548.06%. Westmount Energy's return on equity of -2.93% beat ValiRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ValiRx	-6,548.06%	-71.49%	-35.98%
Westmount Energy	-232.19%	-2.93%	-3.04%

Summary

Westmount Energy beats ValiRx on 7 of the 11 factors compared between the two stocks.

Get ValiRx News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

VAL vs. The Competition

Export

Metric	ValiRx	Oil, Gas & Consumable Fuels Industry	Energy Sector	LON Exchange
Market Cap	£1.61M	£11.22B	£9.80B	£2.90B
Dividend Yield	0.63%	10.25%	10.70%	6.22%
P/E Ratio	-0.23	17.43	20.47	366.25
Price / Sales	51.34	663.52	541.59	89,589.84
Price / Cash	62.50	40.80	36.87	27.89
Price / Book	0.05	4.81	4.31	6.34
Net Income	-£5.71M	£5.28B	£4.35B	£5.89B
7 Day Performance	-12.86%	-1.29%	-1.24%	-0.03%
1 Month Performance	-21.29%	0.12%	-0.36%	11.15%
1 Year Performance	-79.29%	27.73%	28.92%	18.38%

ValiRx Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
VAL ValiRx	N/A	GBX 0.12 -2.4%	N/A	-79.5%	£1.61M	£31.37K	N/A	5,450	Gap Down
TRP Tower Resources	N/A	GBX 0.01 -6.7%	N/A	-58.8%	£6.32M	N/A	N/A	7,480	News Coverage Gap Up
SENX Serinus Energy	N/A	GBX 3.30 flat	N/A	+0.0%	£6.19M	£27.51M	N/A	N/A
BLVN Bowleven	N/A	N/A	N/A	N/A	£5.20M	N/A	N/A	4	Gap Down High Trading Volume
IOG IOG	N/A	N/A	N/A	N/A	£4.99M	£75.41M	N/A	51	Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:VAL) was last updated on 9/29/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

ValiRx (VAL) Competitors

VAL vs. TRP, SENX, BLVN, IOG, and WTE

How does ValiRx compare to Tower Resources?

Summary

How does ValiRx compare to Serinus Energy?

Summary

How does ValiRx compare to Bowleven?

Summary

How does ValiRx compare to IOG?

Summary

How does ValiRx compare to Westmount Energy?

Summary

Media Sentiment Over Time

VAL vs. The Competition

ValiRx Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

ValiRx (VAL) Competitors

VAL vs. TRP, SENX, BLVN, IOG, and WTE

How does ValiRx compare to Tower Resources?

Which has stronger earnings and valuation, VAL or TRP?

Does the media refer more to VAL or TRP?

Do insiders & institutionals hold more shares of VAL or TRP?

Which has more risk & volatility, VAL or TRP?

Is VAL or TRP more profitable?

Summary

How does ValiRx compare to Serinus Energy?

Which has preferable earnings and valuation, VAL or SENX?

Does the media favor VAL or SENX?

Do institutionals & insiders have more ownership in VAL or SENX?

Which has more volatility and risk, VAL or SENX?

Is VAL or SENX more profitable?

Summary

How does ValiRx compare to Bowleven?

Do insiders & institutionals hold more shares of BLVN or VAL?

Which has more volatility & risk, BLVN or VAL?

Does the media favor BLVN or VAL?

Is BLVN or VAL more profitable?

Which has higher valuation & earnings, BLVN or VAL?

Summary

How does ValiRx compare to IOG?

Is VAL or IOG more profitable?

Do institutionals and insiders hold more shares of VAL or IOG?

Which has more risk and volatility, VAL or IOG?

Which has stronger earnings and valuation, VAL or IOG?

Does the media prefer VAL or IOG?

Summary

How does ValiRx compare to Westmount Energy?

Does the media favor VAL or WTE?

Do institutionals and insiders believe in VAL or WTE?

Which has more volatility & risk, VAL or WTE?

Which has stronger earnings & valuation, VAL or WTE?

Is VAL or WTE more profitable?

Summary

Media Sentiment Over Time

VAL vs. The Competition

ValiRx Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools